DRW Securities’s GSK GSK Stock Holding History

DRW Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.7M	Buy	212,287 +152,749	+257%	+$8.28M	0.16%	62
2025 Q4	$2.92M	Buy	59,538 +46,718	+364%	+$2.18M	0.08%	162
2025 Q3	$554K	Buy	+12,820	New	+$501K	0.01%	561
2020 Q4	–	Sell	-8,819	Closed	-$415K	–	161
2020 Q3	$415K	Buy	8,819 +1,109	+14%	+$55.6K	0.02%	105
2020 Q2	$393K	Buy	+7,710	New	+$396K	0.02%	130
2020 Q1	–	Sell	-15,146	Closed	-$890K	–	324
2019 Q4	$890K	Sell	15,146 -85,526	-85%	-$4.76M	0.03%	96
2019 Q3	$5.37M	Buy	+100,672	New	+$5.18M	0.37%	30
2018 Q1	–	Sell	-7,226	Closed	-$320K	–	303
2017 Q4	$320K	Buy	+7,226	New	+$334K	0.03%	305
2016 Q2	–	Sell	-44,000	Closed	-$2.23M	–	81
2016 Q1	$2.23M	Buy	+44,000	New	+$2.19M	0.14%	29
2015 Q2	–	Sell	-32,000	Closed	-$1.85M	–	116
2015 Q1	$1.85M	Buy	32,000 +12,000	+60%	+$688K	0.29%	31
2014 Q4	$1.07M	Buy	+20,000	New	+$1.12M	0.12%	57

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DRW Securities's GSK Position: Q1 2026 in Review

DRW Securities increased its GSK (GSK) stake by 257% in Q1 2026, buying an estimated $8.28M and bringing the position to 212,287 shares worth $11.7M. The position accounts for 0.16% of the portfolio, ranked #62.

DRW Securities first reported a position in GSK in Q4 2014 and has held it in 11 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

DRW Securities held 212,287 shares of GSK worth $11.7M as of Q1 2026.
DRW Securities bought 152,749 GSK shares in Q1 2026, an estimated $8.28M.
GSK made up 0.16% of DRW Securities's portfolio in Q1 2026, its #62 holding.
DRW Securities first reported a position in GSK in Q4 2014 and has held it in 11 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.